These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9143880)

  • 1. Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: enhancement of the anti-melittin response by a synthetic T helper (Th)-cell epitope.
    Hoffmann P; Loleit M; Mittenbühler K; Beck W; Wiesmüller KH; Jung G; Bessler WG
    FEMS Immunol Med Microbiol; 1997 Apr; 17(4):225-34. PubMed ID: 9143880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization.
    Bessler WG; Baier W; vd Esche U; Hoffmann P; Heinevetter L; Wiesmüller KH; Jung G
    Behring Inst Mitt; 1997 Feb; (98):390-9. PubMed ID: 9382763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide.
    Sarobe P; Lasarte JJ; Golvano J; Gullón A; Civeira MP; Prieto J; Borrás-Cuesta F
    Eur J Immunol; 1991 Jun; 21(6):1555-8. PubMed ID: 1710570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug specific antibodies: T-cell epitope-lipopeptide conjugates are potent adjuvants for small antigens in vivo and in vitro.
    Mittenbühler K; Loleit M; Baier W; Fischer B; Sedelmeier E; Jung G; Winkelmann G; Jacobi C; Weckesser J; Erhard MH; Hofmann A; Bessler W; Hoffmann P
    Int J Immunopharmacol; 1997 May; 19(5):277-87. PubMed ID: 9439766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten.
    Reitermann A; Metzger J; Wiesmüller KH; Jung G; Bessler WG
    Biol Chem Hoppe Seyler; 1989 Apr; 370(4):343-52. PubMed ID: 2757794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial cell wall components as immunomodulators--I. Lipopeptides as adjuvants for parenteral and oral immunization.
    Bessler WG; Heinevetter L; Wiesmüller KH; Jung G; Baier W; Huber M; Lorenz AR; Esche UV; Mittenbühler K; Hoffmann P
    Int J Immunopharmacol; 1997; 19(9-10):547-50. PubMed ID: 9637352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a helper T cell epitope recognized by mice of a low responder major histocompatibility type.
    Kim JE; Kojima M; Houghten R; Pendleton CD; Cornette JL; DeLisi C; Berzofsky JA
    Mol Immunol; 1990 Oct; 27(10):941-6. PubMed ID: 1700286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunisation of mice with GnRH lipopeptide vaccine candidates: Importance of T helper or multi-dimer GnRH epitope.
    Goodwin D; Simerska P; Chang CH; Mansfeld FM; Varamini P; D'Occhio MJ; Toth I
    Bioorg Med Chem; 2014 Sep; 22(17):4848-54. PubMed ID: 25059504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic lipopeptides as novel adjuvants.
    Bessler WG; Jung G
    Res Immunol; 1992 Jun; 143(5):548-53; discussion 579-80. PubMed ID: 1439136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F; Gras-Masse H; Boutillon C; Chirat F; Deprez B; Guillet JG; Gomard E; Tartar A; Levy JP
    J Immunol; 1992 Nov; 149(10):3416-22. PubMed ID: 1385524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.
    Matyas GR; Mayorov AV; Rice KC; Jacobson AE; Cheng K; Iyer MR; Li F; Beck Z; Janda KD; Alving CR
    Vaccine; 2013 Jun; 31(26):2804-10. PubMed ID: 23624097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant effects of various lipopeptides and interferon-gamma on the humoral immune response of chickens.
    Erhard MH; Schmidt P; Zinsmeister P; Hofmann A; Münster U; Kaspers B; Wiesmüller KH; Bessler WG; Stangassinger M
    Poult Sci; 2000 Sep; 79(9):1264-70. PubMed ID: 11020070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.
    Sad S; Rao K; Arora R; Talwar GP; Raghupathy R
    Immunology; 1992 Aug; 76(4):599-603. PubMed ID: 1383134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes.
    Boeckler C; Dautel D; Schelté P; Frisch B; Wachsmann D; Klein JP; Schuber F
    Eur J Immunol; 1999 Jul; 29(7):2297-308. PubMed ID: 10427993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific, MHC-restricted B cell activation by cell-free Th2 cell products. Synergy between antigen-specific helper factors and IL-4.
    Guy R; Hodes RJ
    J Immunol; 1989 Sep; 143(5):1433-40. PubMed ID: 2474597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.
    Ohtake J; Ohkuri T; Togashi Y; Kitamura H; Okuno K; Nishimura T
    Immunol Lett; 2014 Sep; 161(1):20-30. PubMed ID: 24794408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population.
    Zeng W; Horrocks KJ; Tan ACL; Wong CY; Chua BY; Jackson DC
    Vaccine; 2020 Jan; 38(3):597-607. PubMed ID: 31740096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.